A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...

You may be reading this because you or someone you care about has nasal cavity or sinus cancer. Learning more can help you get ready to talk with your healthcare provider and understand the next steps ...

Researchers examined trends in the utilization of various surgical procedures for skin cancer stratified by patient skin color.

Leading dermatologists have suggested President Trump may be suffering from actinic keratosis, an unsightly skin condition ...

Delayed full-thickness skin grafting after skin cancer resection was associated with a higher rate of graft success than immediate skin grafting.

Australia has experienced a more than doubling of penile cancer cases over the last two decades and it’s puzzling health ...

The presentation of chronic feline gingivostomatitis is often dramatic. Clinical signs include severe refractory gingivostomatitis, halitosis, ptyalism, and unkempt hair coats due to a lack of ...

WHEN Margot Blair began suffering from persistent mouth ulcers, she thought little of it. The now 62-year-old, from Dumfries, ...

The NHS has shared eight key symptoms of eye cancer to watch for, including subtle signs that are often overlooked ...

Leading dermatologists have suggested President Trump may be suffering from actinic keratosis, an unsightly skin condition that can turn cancerous.

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...